These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
605 related items for PubMed ID: 14578014
21. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center. Moore PW, Donovan JW, Burkhart KK, Waskin JA, Hieger MA, Adkins AR, Wert Y, Haggerty DA, Rasimas JJ. J Med Toxicol; 2014 Jun; 10(2):126-32. PubMed ID: 24619543 [Abstract] [Full Text] [Related]
22. Oxazepam versus clomethiazol in alcohol withdrawal treatment. de Millas W, Ganzer F, Kuhn S, Haasen C. Eur Addict Res; 2010 Jun; 16(4):179-84. PubMed ID: 20606442 [Abstract] [Full Text] [Related]
23. A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms. Lader M, Olajide D. J Clin Psychopharmacol; 1987 Feb; 7(1):11-5. PubMed ID: 2880872 [Abstract] [Full Text] [Related]
24. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome. Janiri L, Martinotti G, Tonioni F, Ghelardini C, Nicolai R, Galeotti N, Mosconi L, Calvani M, Bartolini A, Iannoni E. Clin Neuropharmacol; 2009 Feb; 32(1):35-40. PubMed ID: 18978503 [Abstract] [Full Text] [Related]
25. [Benzodiazepine antagonism by RO 15-1788: psychometric, hormonal and biophysical parameters]. Noderer J, Duka T, Dorow R. Anaesthesist; 1988 Aug; 37(8):535-42. PubMed ID: 2902813 [Abstract] [Full Text] [Related]
26. Effects of the combination of metyrapone and oxazepam on cocaine craving and cocaine taking: a double-blind, randomized, placebo-controlled pilot study. Kablinger AS, Lindner MA, Casso S, Hefti F, DeMuth G, Fox BS, McNair LA, McCarthy BG, Goeders NE. J Psychopharmacol; 2012 Jul; 26(7):973-81. PubMed ID: 22236504 [Abstract] [Full Text] [Related]
27. Low risk of seizures with slow flumazenil infusion and routine anticonvulsant prophylaxis for high-dose benzodiazepine dependence. Tamburin S, Faccini M, Casari R, Federico A, Morbioli L, Franchini E, Bongiovanni LG, Lugoboni F. J Psychopharmacol; 2017 Oct; 31(10):1369-1373. PubMed ID: 28613124 [Abstract] [Full Text] [Related]
28. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Addolorato G, Balducci G, Capristo E, Attilia ML, Taggi F, Gasbarrini G, Ceccanti M. Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990 [Abstract] [Full Text] [Related]
29. A programme for short-term withdrawal from benzodiazepines in geriatric hospital inpatients: success rate and effect on subjective sleep quality. Petrovic M, Pevernagie D, Van Den Noortgate N, Mariman A, Michielsen W, Afschrift M. Int J Geriatr Psychiatry; 1999 Sep; 14(9):754-60. PubMed ID: 10479747 [Abstract] [Full Text] [Related]
30. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years. Kisicki JC, Fiske K, Lyne A. Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196 [Abstract] [Full Text] [Related]
31. Precipitated abstinence in orally dosed benzodiazepine-dependent dogs. Martin WR, Sloan JW, Wala E. J Pharmacol Exp Ther; 1990 Nov; 255(2):744-55. PubMed ID: 1978731 [Abstract] [Full Text] [Related]
32. Benzodiazepine dependence and its treatment with low dose flumazenil. Hood SD, Norman A, Hince DA, Melichar JK, Hulse GK. Br J Clin Pharmacol; 2014 Feb; 77(2):285-94. PubMed ID: 23126253 [Abstract] [Full Text] [Related]
33. In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods. McGregor C, Machin A, White JM. Drug Alcohol Rev; 2003 Jun; 22(2):175-80. PubMed ID: 12850904 [Abstract] [Full Text] [Related]
34. [Postoperative agitation. A new cause]. Madi S, Langonnet F. Cah Anesthesiol; 1988 Nov; 36(7):509-12. PubMed ID: 2905629 [Abstract] [Full Text] [Related]
35. [The efficacy of the native flumazenil for acute poisoning with benzodiazepines]. Zhu XH, Li JX, Wang F. Hunan Yi Ke Da Xue Xue Bao; 2000 Dec 28; 25(6):576-8. PubMed ID: 12516410 [Abstract] [Full Text] [Related]
36. Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind study. Stuppaeck CH, Pycha R, Miller C, Whitworth AB, Oberbauer H, Fleischhacker WW. Alcohol Alcohol; 1992 Mar 28; 27(2):153-8. PubMed ID: 1524606 [Abstract] [Full Text] [Related]
37. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial. Pomier-Layrargues G, Giguère JF, Lavoie J, Perney P, Gagnon S, D'Amour M, Wells J, Butterworth RF. Hepatology; 1994 Jan 28; 19(1):32-7. PubMed ID: 8276366 [Abstract] [Full Text] [Related]
38. The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient. Krystal AD, Watts BV, Weiner RD, Moore S, Steffens DC, Lindahl V. J ECT; 1998 Mar 28; 14(1):5-14. PubMed ID: 9661088 [Abstract] [Full Text] [Related]
39. Opioid and benzodiazepine withdrawal syndrome in adult burn patients. Brown C, Albrecht R, Pettit H, McFadden T, Schermer C. Am Surg; 2000 Apr 28; 66(4):367-70; discussion 370-1. PubMed ID: 10776874 [Abstract] [Full Text] [Related]
40. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Daeppen JB, Gache P, Landry U, Sekera E, Schweizer V, Gloor S, Yersin B. Arch Intern Med; 2002 May 27; 162(10):1117-21. PubMed ID: 12020181 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]